GlassScriptPhysician profile
Brian Sheehan
NPI 1063808707
$2,432.79
in general payments reported to CMS, 2019-2025
9 companies · $527 in 2025
The $527 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $1,505 · 2024: $293 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.89 |
| Education | $110.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,114.59 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $660.91 | 2022-2023 | Endurant Iis, Abre, Valiant Captivia |
| Penumbra, INC. | $145.27 | 2025 | Ruby Coil |
| Boston Scientific Corporation | $124.05 | 2023 | |
| Shockwave Medical, INC | $116.14 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ge Healthcare | $92.12 | 2025 | |
| Cook Medical LLC | $88.56 | 2023 | Zenith, Cook |
| Philips North America LLC | $54.72 | 2022-2023 | |
| Silk Road Medical, INC. | $36.43 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.